Stay updated on IMbrave150 Clinical Trial: Atezo-Bev vs. Sorafenib
Sign up to get notified when there's something new on the IMbrave150 Clinical Trial: Atezo-Bev vs. Sorafenib page.

Latest updates to the IMbrave150 Clinical Trial: Atezo-Bev vs. Sorafenib page
- CheckyesterdayNo Change Detected
- Check16 days agoChange DetectedAn added revision v3.5.5 and removal of v3.5.4 are shown, reflecting an internal version update rather than substantive content changes. The displayed study details remain unchanged.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, indicating an internal update to the page's template or content management system.SummaryDifference0.0%

- Check44 days agoChange DetectedTaiwan site entry updated in the locations list: Taoyuan, Taiwan, 333 was removed and Taoyuan County, Taiwan, 333 was added. This reflects a site name adjustment in the same region.SummaryDifference0.0%

- Check52 days agoChange DetectedA new revision entry, v3.5.3, was added to the page, replacing the previous v3.5.2. This reflects an updated version or patch release being recorded as the current revision.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page’s displayed revision/version has been updated from **v3.5.0** to **v3.5.2**.SummaryDifference0.0%

- Check73 days agoChange DetectedLocation entry updated to Padova, Veneto, Italy (35128), replacing Padua for the site.SummaryDifference0.0%

Stay in the know with updates to IMbrave150 Clinical Trial: Atezo-Bev vs. Sorafenib
Enter your email address, and we'll notify you when there's something new on the IMbrave150 Clinical Trial: Atezo-Bev vs. Sorafenib page.